Molecular and Cellular Analysis of Breast Cancer

Breast - Female Clinical Trial

Official title:
Molecular and Cellular Analysis of Breast Cancer

Status Suspended

Clinical Trial Summary

The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond to various treatments.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02243397
Study type	Observational
Source	Stanford University
Contact
Status	Suspended
Phase
Start date	September 2014
Completion date	September 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02601027` - Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA	Phase 3
Completed	`NCT03018080` - Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer	Phase 2
Completed	`NCT03162887` - Educational Module and Decision Counseling Program in Increasing Mammography Screening Rates in Formerly Homeless Women With Serious Mental Illness	N/A
Completed	`NCT01970670` - Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer